Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say By: MarketWatch November 10, 2023 at 08:59 AM EST Company will halt development of experimental depression treatment Read More >> Related Stocks: Neurocrine Bioscienc Takeda Pharmaceutical Ltd ADR
